Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.
暂无分享,去创建一个
Ya-Chen Tina Shih | Jeffrey M Albert | Yu Shen | Karen E Hoffman | Benjamin D Smith | Diane D. Liu | Diane D Liu | T. Buchholz | Benjamin D. Smith | K. Hoffman | Yu Shen | S. Giordano | J. Albert | Y. Shih | I. Pan | Thomas A Buchholz | Sharon H Giordano | I-Wen Pan | Benjamin D. Smith | Jeffrey M. Albert | Diane D. Liu | Yu Shen | I-Wen Pan | Ya-Chen Tina Shih | Karen E. Hoffman | Thomas A. Buchholz | S. H. Giordano
[1] Melania Pintilie,et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.
[2] M Kalder,et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] C. Gross,et al. Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There? , 2002, Annals of Internal Medicine.
[4] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[5] C Bain,et al. Threats to Applicability of Randomised Trials: Exclusions and Selective Participation , 1999, Journal of health services research & policy.
[6] I. Kunkler,et al. Breast radiotherapy: considerations in older patients. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] Michael W Kattan,et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Benjamin D Smith,et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] B. Hillner,et al. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Dennis Ross-Degnan,et al. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer , 2011, Breast Cancer Research and Treatment.
[11] G. Raj,et al. How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] L. Tabár,et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Michael W Kattan,et al. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Pötter,et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. , 2005, International journal of radiation oncology, biology, physics.
[15] Mithat Gonen,et al. Individualized prediction of colon cancer recurrence using a nomogram. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Catherine Legrand. 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .
[17] Hiram S. Cody,et al. A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.
[18] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[19] M. Kattan,et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2006, Journal of the National Cancer Institute.
[20] Edi Brogi,et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Robert Gray,et al. Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Timothy L Lash,et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Aliza K Fink,et al. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Murray F. Brennan,et al. Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas , 2004, Annals of surgery.
[25] Jerry Avorn,et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[27] T. Pajak,et al. Compliance with breast‐conservation standards for patients with early‐stage breast carcinoma , 2003, Cancer.
[28] A. Vanderwalde,et al. Early breast cancer in the older woman. , 2012, Clinics in geriatric medicine.
[29] J. Manson,et al. Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention , 2011, Cancer Prevention Research.
[30] Timothy L. Lash,et al. Adherence to tamoxifen over the five-year course , 2006, Breast Cancer Research and Treatment.
[31] C. Gross,et al. Effectiveness of radiation therapy for older women with early breast cancer. , 2006, Journal of the National Cancer Institute.
[32] D Spiegelman,et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.
[33] E Marubini,et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] Barbara L. Smith,et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.
[35] Barbara L. Smith,et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] F. Camacho,et al. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Norman Wolmark,et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.